Tectonic lamellar keratoplasty with acellular corneal stroma in high-risk corneal transplantation

Mol Vis. 2011:17:1909-17. Epub 2011 Jul 15.

Abstract

Purpose: Tectonic lamellar keratoplasty (TLKP) is a primary surgical procedure to improve the condition of the recipient bed in high-risk corneal transplantation. It is usually performed for a secondary optical penetrating keratoplasty (PKP). The present study was undertaken to explore a new strategy for TLKP using acellular corneal stroma (ACS) prepared by decellularization.

Methods: ACS for TLKP was prepared from cat cornea by decellularization. The efficiency of the decellularization was examined by hematoxylin and eosin (H&E) staining and through DNA content analysis. Twenty-eight New Zealand white rabbits, as recipients, were assigned to one of two groups that had different material for their TLKP. The TLKP was combined with a central optical PKP as a single-stage procedure. Either ACS or fresh cat corneal lamella, 11.25 mm in diameter, was used for the TLKP in these two groups. After TLKP, a 6.5-mm full-thickness cat cornea was placed in the central cornea of each recipient rabbit for PKP. Clinical outcomes and the histology of the transplants were compared post-operatively.

Results: ACS for TLKP prolonged the survival of the transplants. The mean survival time of the transplants in the ACS group (36.4±4.3 days) was longer than for those in the control group (14.0±2.2 days, p<0.05). The ACS group showed a significantly smaller neovascularization area compared to the control group. The areas of corneal neovascularization were 5.3±1.1 mm² and 45.2±4.9 mm² (p<0.05), respectively, after two weeks, and 25.1±4.7 mm² and 105.3±12.4 mm² (p<0.05), respectively, after four weeks. Histology revealed that fewer inflammatory cells were infiltrating the transplants in the ACS group than those in the control group.

Conclusions: The use of ACS for TLKP prolonged the survival of corneal transplants, reduced corneal neovascularization, and prevented from infiltration of inflammatory cells. It is a feasible and effective strategy to prolong the survival of transplants in high-risk corneal transplantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Cats
  • Corneal Neovascularization / pathology
  • Corneal Neovascularization / prevention & control
  • Corneal Stroma / drug effects
  • Corneal Stroma / transplantation*
  • Corneal Transplantation / methods*
  • Deoxycholic Acid / pharmacology
  • Eosine Yellowish-(YS) / analysis
  • Graft Rejection / prevention & control
  • Graft Survival*
  • Hematoxylin / analysis
  • Humans
  • Immunohistochemistry
  • Keratoplasty, Penetrating / methods*
  • Rabbits
  • Risk Factors
  • Transplantation, Heterologous

Substances

  • Anti-Bacterial Agents
  • Deoxycholic Acid
  • Eosine Yellowish-(YS)
  • Hematoxylin